[CRISPR/Cas9: From research to therapeutic application]

Area of Science:

• Molecular Biology
• Genetics
• Biotechnology

Context:

• Genome engineering is crucial for understanding and treating genetic disorders.
• CRISPR/Cas9, zinc-finger nucleases (ZFN), and transcription activator-like effectors (TALEN) are key genome editing technologies.
• CRISPR/Cas9 has emerged as the most efficient tool compared to its predecessors.

Purpose:

• To highlight the efficiency and applications of CRISPR/Cas9 technology in genome editing.
• To discuss the role of CRISPR/Cas9 in developing treatments for diseases and in genetic disease modeling.
• To acknowledge the ongoing research and potential of CRISPR/Cas9 in therapeutic development.

Summary:

• CRISPR/Cas9, a bacterial adaptive immune system, enables precise gene cutting and modification across diverse organisms.
• It surpasses ZFN and TALEN in efficiency for genome editing applications.
• The technology is being actively developed for treating cancers, cardiovascular, and ophthalmic disorders, and for creating accurate genetic disease models.

Impact:

• CRISPR/Cas9 offers significant advancements in therapeutic research for genetic diseases.
• It provides researchers with powerful tools for genetic disease modeling and understanding pathological mechanisms.
• Despite ethical considerations, CRISPR/Cas9 represents a hopeful frontier in global health innovation.